No Data
No Data
Meihua Biotech 2024 Annual Report (English version)
Meihua Holdings Group (600873) Review: Q1 performance exceeded expectations. Bullish on the recovery of the demand for MSG and amino acids.
The company released its Q1 2025 financial report: During the reporting period, the company achieved revenue of 6.269 billion yuan (YoY -3%, QoQ -2%), and net income attributable to the parent company of 1.019 billion yuan (YoY +36%, QoQ +37%).
MeiHua Holdings Group Q1 Profit Up 36%; Shares Rise 4%
Meihua Biotech: Meihua Biotech\'s 2025 First Quarter Report
Meihua Biotech Announces Business Data for the First Quarter of 2025
Meihua Biotech\'s 2025 First Quarter Report